Associated Papers
Accurate affinity models for SH2 domains from peptide binding assays and free-energy regression.
Gagoski D et al.
Protein Science : a Publication of the Protein Society, 2025
Accurate sequence-to-affinity models for SH2 domains from multi-round peptide binding assays coupled with free-energy regression.
Gagoski D et al.
Biorxiv : the Preprint Server for Biology, 2025
Longitudinal analysis of treatment-induced genomic alterations in gliomas.
Erson-Omay EZ et al.
Genome Medicine, 2017
AKT in cancer: new molecular insights and advances in drug development.
Mundi PS et al.
British Journal of Clinical Pharmacology, 2016
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology.
Ibarrola-Villava M et al.
Oncotarget, 2016
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
Kopetz S et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2015
Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia.
Nellist M et al.
Molecular Genetics and Metabolism, 2015
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Griewank KG et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2013
Proteome-wide analysis of amino acid variations that influence protein lysine acetylation.
Suo SB et al.
Journal of Proteome Research, 2013
Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers.
Parikh C et al.
Proceedings of the National Academy of Sciences of the United States of America, 2012
Somatic activation of AKT3 causes hemispheric developmental brain malformations.
Poduri A et al.
Neuron, 2012
Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece.
Sozopoulos E et al.
Endocrine Pathology, 2010
PTEN signaling in brain: neuropathology and tumorigenesis.
Endersby R et al.
Oncogene, 2008
PI3K/AKT pathway genetic alterations and dysregulation of expression in bladder cancer.
Kachrilas S et al.
Journal of B.u.on. : Official Journal of the Balkan Union of Oncology, 0